Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis.
about
Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control StudiesPrognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysisNoncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and BiomarkersSex hormones, hormonal interventions, and gastric cancer risk: a meta-analysisEtiology and Prevention of Gastric CancerEpstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease?Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data.Using routinely collected data to stratify prostate cancer patients into phases of care in the United Kingdom: implications for resource allocation and the cancer survivorship programme.Molecular classifications of gastric cancers: Novel insights and possible future applications.Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer.Prevention strategies for gastric cancer: a global perspectiveEpstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients.Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia.Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern ChinaCase–control study of Epstein–Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease.Epstein-Barr virus infection and gastric cancer: a systematic review.Projections of cancer prevalence in the United Kingdom, 2010-2040Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profileAssessment of Epstein-Barr virus nucleic acids in gastric but not in breast cancer by next-generation sequencing of pooled Mexican samples.Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB.Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancersComprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.Evidence of Epstein-Barr virus association with gastric cancer and non-atrophic gastritis.Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancerThe biological properties of different Epstein-Barr virus strains explain their association with various types of cancersEpstein-Barr Virus (EBV)-associated gastric carcinoma.Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed?Xenophagy in Helicobacter pylori- and Epstein-Barr virus-induced gastric cancer.Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomasEpstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review.Heterogeneity of the Epstein-Barr virus major internal repeat reveals evolutionary mechanisms of EBV and a functional defect in the prototype EBV strain B95-8.Correlation Between Infection Status of Epstein-Barr Virus and 18F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer.The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors.Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
P2860
Q26750911-C0ABE7B1-FAB2-4338-BE2E-BB7BC91B60DEQ26779692-A7361518-1659-4B76-9A84-87A015CED73BQ26785700-BDFBBB98-C4F2-4581-AFE0-705875A5E198Q26823102-BE2E9583-2069-4E3D-889A-20598C2D0099Q28072819-C293DFF2-056E-4574-B01B-536EBE631C22Q28075698-5A1C254F-ADBB-46C0-9746-9C58D36251D0Q30610963-07782001-B9BE-4569-9DEE-FD2EFE7D6A1BQ30702069-1D6EFD00-DD74-432F-9706-0770326E70A7Q30912685-69DC97C4-A379-4605-9ADD-CDED0AA82533Q33696201-983EDBCD-C9F3-48AB-BDF8-88E8905B1B96Q33709895-09F3663F-1D11-4D70-B75A-800A3BA4F5B3Q34658645-4EDD19E6-D582-4BF9-9D96-5005112ED5E1Q34702051-C1282B01-BDA9-49A2-A24D-8BF4622609A1Q35238430-BB485730-920F-402D-829E-581948E7282BQ35258785-CEF9ECA8-3485-45F0-B1C0-84B88BABAAC7Q35550673-A5C36583-14FA-49E4-96EC-F8C3207F0625Q35918250-A25109B4-1A0C-4D27-B6BA-6F55428DF984Q36086830-BFE80092-35B7-4410-B7B6-21F103AFB4B9Q36153008-FB0A197F-827F-4233-B4BE-250D46BA43BAQ36287990-559F9AFE-FAD4-4868-892A-360D5069F7DEQ36374816-515F2FF1-305C-499B-BFDF-D5EC79CD0D3AQ36399985-BB1D6308-F201-471B-9E45-D5871A87B568Q36687528-549EA78D-F362-4DC1-945D-A9264C2A537CQ36720261-D4FAF010-1111-4E20-AD19-7AF1432C5BA9Q36782621-88E39895-4D6A-48B5-9A35-17B14B006150Q37252852-59E29940-C768-4E31-88F2-DFF31F538C95Q37362803-AFF4FA63-6C60-4661-B615-7759427E9A5EQ37536970-BC7ECE25-267E-4DAF-BE2F-B1AFF99BDA76Q37566742-AB10C1C9-204B-4B54-A640-2039D9098AE1Q37653908-0EE26294-1CA1-4C25-8750-EA50C2F5863CQ37705818-91F84E43-1823-4800-AB52-BC5218A5427CQ38076138-3B966DB3-DF70-47CA-9207-6A1577B62DC4Q38150281-9129111B-CF06-4CE6-93F7-94012DC4525FQ38196348-4DC8BC98-F14A-4A77-A3C0-9ACFF02ED2BBQ38296711-A6F0E8FB-8BEB-4DF5-A2C4-0405B2171168Q38766316-1D59C523-F564-4B5E-955B-BF40D9DD44F2Q40042378-29164FB2-1020-483D-A606-F7A36F264D6AQ40144662-E1EEBEA4-8785-4733-997F-0D0FCA517C55Q43046461-3F3511D3-6630-4F9A-BC48-0C790479AE5DQ45324790-6F8FF684-7EAB-4711-851F-B5B64F70E5C2
P2860
Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Determinants of Epstein-Barr v ...... international pooled analysis.
@ast
Determinants of Epstein-Barr v ...... international pooled analysis.
@en
type
label
Determinants of Epstein-Barr v ...... international pooled analysis.
@ast
Determinants of Epstein-Barr v ...... international pooled analysis.
@en
prefLabel
Determinants of Epstein-Barr v ...... international pooled analysis.
@ast
Determinants of Epstein-Barr v ...... international pooled analysis.
@en
P2093
P2860
P356
P1476
Determinants of Epstein-Barr v ...... international pooled analysis
@en
P2093
C Koriyama
C S Rabkin
E Carrascal
E Yoshiwara-Wakabayashi
M C Camargo
R Herrera-Goepfert
P2860
P2888
P356
10.1038/BJC.2011.215
P407
P50
P577
2011-06-07T00:00:00Z